Clinical Trial Update: Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial exploring ustekinumab for Type 1 Diabetes is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: University of British Columbia | Conditions: Type 1 Diabetes Mellitus | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING